STATCenter·
STAT+: Moderna co-founder Kenneth Chien on the future of mRNA — and Moderna
In a Q&A, Kenneth Chien, no longer with Moderna, predicts the company's mRNA cancer vaccine will be transformative for biotech.
Read at STAT →
In a Q&A, Kenneth Chien, no longer with Moderna, predicts the company's mRNA cancer vaccine will be transformative for biotech.

<iframe src="https://statesidedaily.com/embed/cluster/de53a1136ec363de99d9599c106e8d7eb165e23f" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: Moderna co-founder Kenneth Chien on the future of mRNA — and Moderna"></iframe>